Probability of malignancy and molecular alterations as determined by ThyroSeq v3 genomic classifier in Bethesda Category IV.

Cancer cytopathology(2023)

引用 1|浏览5
暂无评分
摘要
The MDROM and ROM were trending lower in OFN compared with FN, and the molecular alterations differed between OFN and FN subcategories.
更多
查看译文
关键词
thyroseq v3,genomic classifier,bethesda category iv,malignancy,molecular alterations
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要